Advertisement
Advertisement

BGNE

BGNE logo

BeiGene, Ltd. - ADR

184.71
USD
0
0.00%
Dec 31, 15:59 UTC -5
Closed
exchange

After-Market

184.755

+0.04
+0.02%

BeiGene, Ltd. - ADR Profile

About

BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.

Info & Links

CEO

John V. Oyler

Headquarters

94 SOLARIS AVENUE, CAMANA BAY
GRAND CAYMAN, E9 KY1-1108, CAYMAN ISLANDS

Industry

Other

Sector

Other

Website

www.beigene.com

Auditor

Ernst & Young LLP

Share holders

39,817

Employees

10,600

BeiGene, Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

19.63B

Enterprise Value

17.98B

Enterprise Value/EBITDA(ttm)

-24.72

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

5.44

Price to Book(mrq)

5.23

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

83.70%

Operating Margin(ttm)

-25.94%

Profit Margin(ttm)

-29.11%

Return on Equity(ttm)

-25.12%

Return on Invested Capital(ttm)

-23.64%

Return on Assets(ttm)

-14.95%

Income Statement

Revenue(ttm)

3.32B

Revenue Per Share(ttm)

2.39

Gross Profit(ttm)

2.78B

EBITDA(ttm)3

-727.23M

Net Income Available to Common(ttm)

-860.46M

Diluted EPS(ttm)

-8.24

Share Statistics

Beta (5Y Monthly)

0.62

52-Week Change

23.20%

S&P 500 52-Week Change

21.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.39B

Dividend Yield

0.00%

Float4

90.36M

% Held by Insiders

7.43%

% Held by Institutions

48.55%

Balance Sheet

Total Cash(mrq)

2.70B

Total Cash Per Share(mrq)

1.95

Total Debt(mrq)

1.05B

Total Debt/Equity(mrq)

30.60%

Current Ratio(mrq)

1.93%

Quick Ratio(mrq)

1.72%

Book Value Per Share(mrq)

32.23

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.04

Free Cash Flow(ytd)

-615.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement